![A mix-and-match approach to COVID-19 vaccines could provide logistical and immunological benefits | PBS NewsHour A mix-and-match approach to COVID-19 vaccines could provide logistical and immunological benefits | PBS NewsHour](https://d3i6fh83elv35t.cloudfront.net/static/2021/06/GettyImages-1232570041-1024x696.jpg)
A mix-and-match approach to COVID-19 vaccines could provide logistical and immunological benefits | PBS NewsHour
![COVID-19 Booster Vaccine: What Is It & When Can I Get It? | BetterMed Urgent Care: Greater Richmond, Fredericksburg & North Carolina COVID-19 Booster Vaccine: What Is It & When Can I Get It? | BetterMed Urgent Care: Greater Richmond, Fredericksburg & North Carolina](https://www.bettermedcare.com/wp-content/uploads/2021/11/COVID-19-Booster-Vaccine-1.png)
COVID-19 Booster Vaccine: What Is It & When Can I Get It? | BetterMed Urgent Care: Greater Richmond, Fredericksburg & North Carolina
![Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases | Annals of the Rheumatic Diseases Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases | Annals of the Rheumatic Diseases](https://ard.bmj.com/sites/default/files/highwire/annrheumdis/81/6.cover-source.jpg)
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases | Annals of the Rheumatic Diseases
![Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens | Nature Communications Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-32321-0/MediaObjects/41467_2022_32321_Fig1_HTML.png)